These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9242991)

  • 21. Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial.
    Fasslrinner F; Schetelig J; Burchert A; Kramer M; Trenschel R; Hegenbart U; Stadler M; Schäfer-Eckart K; Bätzel M; Eich H; Stuschke M; Engenhart-Cabillic R; Krause M; Dreger P; Neubauer A; Ehninger G; Beelen D; Berdel WE; Siepmann T; Stelljes M; Bornhäuser M
    Lancet Haematol; 2018 Apr; 5(4):e161-e169. PubMed ID: 29550384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
    Bill M; Grimm J; Jentzsch M; Kloss L; Goldmann K; Schulz J; Beinicke S; Häntschel J; Cross M; Vucinic V; Pönisch W; Behre G; Franke GN; Lange T; Niederwieser D; Schwind S
    Ann Hematol; 2018 Oct; 97(10):1757-1765. PubMed ID: 29785446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation in first remission.
    Rowe JM
    Leukemia; 1997 May; 11 Suppl 4():S12-4. PubMed ID: 9179274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
    De Fabritiis P; Ferrero D; Sandrelli A; Tarella C; Meloni G; Pulsoni A; Pregno P; Badoni R; De Felice L; Gallo E
    Bone Marrow Transplant; 1989 Nov; 4(6):669-74. PubMed ID: 2819285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
    Robertson MJ; Roy DC; Stone RM; Ritz J
    Prog Clin Biol Res; 1994; 389():47-63. PubMed ID: 7700916
    [No Abstract]   [Full Text] [Related]  

  • 27. [The role of autologous hematopoietic cell transplantation in adult acute myelogenous leukemia].
    Rucińska M; Machaczka M; Piatkowska-Jakubas B; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():44-51. PubMed ID: 10494182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
    Cassileth PA; Harrington DP; Appelbaum FR; Lazarus HM; Rowe JM; Paietta E; Willman C; Hurd DD; Bennett JM; Blume KG; Head DR; Wiernik PH
    N Engl J Med; 1998 Dec; 339(23):1649-56. PubMed ID: 9834301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
    Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of photodynamic therapy in bone marrow purging.
    Mulroney CM; Glück S; Ho AD
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):24-7. PubMed ID: 7992104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
    Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
    Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation in acute leukaemia.
    Gale RP; Champlin RE
    Clin Haematol; 1986 Aug; 15(3):851-72. PubMed ID: 3536244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
    Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial.
    Reiffers J; Gaspard MH; Maraninchi D; Michallet M; Marit G; Stoppa AM; Corront B; David B; Gastaut JA; Scotto JJ
    Br J Haematol; 1989 May; 72(1):57-63. PubMed ID: 2660902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purging with 4-hydroperoxycyclophosphamide.
    Jones RJ
    J Hematother; 1992; 1(4):343-8. PubMed ID: 1345676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous bone marrow transplantation in acute myelogenous leukemia.
    Rizzoli V; Mangoni L; Carlo-Stella C
    Leukemia; 1992 Nov; 6(11):1101-6. PubMed ID: 1434791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autografting for chronic myelogenous leukemia.
    Bhatia R; Verfaillie CM
    Curr Opin Hematol; 1995 Nov; 2(6):436-43. PubMed ID: 9372033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
    Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
    J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.